Abstract

Tissue engineering has recently evolved into a promising approach for annulus fibrosus (AF) regeneration. However, selection of an ideal cell source, which can be readily differentiated into AF cells of various regions, remains challenging because of the heterogeneity of AF tissue. In this study, we set out to explore the feasibility of using transforming growth factor-β3-mediated bone marrow stem cells (tBMSCs) for AF tissue engineering. Since the differentiation of stem cells significantly relies on the stiffness of substrate, we fabricated nanofibrous scaffolds from a series of biodegradable poly(ether carbonate urethane)-urea (PECUU) materials whose elastic modulus approximated that of native AF tissue. We cultured tBMSCs on PECUU scaffolds and compared their gene expression profile to AF-derived stem cells (AFSCs), the newly identified AF tissue-specific stem cells. As predicted, the expression of collagen-I in both tBMSCs and AFSCs increased with scaffold stiffness, whereas the expression of collagen-II and aggrecan genes showed an opposite trend. Interestingly, the expression of collagen-I, collagen-II and aggrecan genes in tBMSCs on PECUU scaffolds were consistently higher than those in AFSCs regardless of scaffold stiffness. In addition, the cell traction forces (CTFs) of both tBMSCs and AFSCs gradually decreased with scaffold stiffness, which is similar to the CTF change of cells from inner to outer regions of native AF tissue. Together, findings from this study indicate that tBMSCs had strong tendency to differentiate into various types of AF cells and presented gene expression profiles similar to AFSCs, thereby establishing a rationale for the use of tBMSCs in AF tissue engineering.

Highlights

  • Intervertebral disc (IVD) degeneration is a major cause of low back pain, a common disease which affects about 80% of the population worldwide [1, 2]

  • Being annulus fibrosus (AF) tissue specific, the newly identified AF-derived stem/progenitor cells (AFSCs) could be a valuable source for AF tissue engineering

  • The differentiation potential of Transforming growth factor b3 (TGF-b3)-mediated bone marrow MSCs (BMSCs), i.e. transforming growth factor-b3-mediated bone marrow stem cells (tBMSCs), towards AF-like cells was studied by comparing with AFSCs

Read more

Summary

Introduction

Intervertebral disc (IVD) degeneration is a major cause of low back pain, a common disease which affects about 80% of the population worldwide [1, 2]. Current treatments for degenerative disc disease (DDD), including discectomy and spinal fusion, only relieve the neurological symptoms, but do not prevent IVD degeneration. They may even cause degenerative post-discectomy spondylosis and adjacent vertebral degeneration [3, 4]. AF cells or mesenchymal stem cells (MSCs) have been used in the majority of AF tissue engineering studies [9,10,11,12,13,14,15]. AF-derived stem/progenitor cells (AFSCs) have been identified in humans, rabbits, rats and minipigs [18,19,20,21].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call